Skip to main content
Home News Page 2

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

Duke’s Aravind Asokan, Ph.D., named Global Scholar

As a Novartis Institute for Biomedical Research (NIBR) Global Scholar, Asokan will receive up to $1 million in funding over three years, along with "drug-hunting expertise from dedicated NIBR scientific collaborators" as part of this…

Read More

Istari Oncology Announces First Patient Dosed in the Non-Muscle-Invasive Bladder Cancer (NMIBC) Substudy of the LUMINOS-103 Basket Trial Evaluating Lerapolturev Monotherapy

Istari Oncology was founded by Drs. Darell Bigner and Matthias Gromeier (Neurosurgery, SOM).

Read More

FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

Radius Health, with its eventual partner Stemline Therapeutics/Menarini Group, licensed the cancer indications for this drug in 2017 out of the lab of Dr. Donald McDonnell (Pharmacology and Cancer Biology, SOM).

Read More

Celebrating Major Milestones in Personalized Orthopaedics, restor3d Announces First Surgery Using the Next Generation Kinos Axiom® Total Ankle System Featuring TIDAL Technology™ and Launches Mobile Companion App of r3id Personalized Surgery Platform

restor3d, a leading medical device company that develops innovative technologies and manufactures 3D printed implants and instruments, celebrates two incredible company milestones. The first being the successful implantation of the next generation Kinos Axiom® Total Ankle…

Read More

PranaQ Secures $3M in Seed Funding

This post first appeared on the PranaQ website. PranaQ, a healthcare technology startup, successfully completed $3M in Seed round funding raising. The round was participated by multiple global venture capital firms, including DSC Investment, Smilegate Investment,…

Read More

FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the evaluation of lung ventilation

Polarean Imaging, a start-up founded by Dr. Bastiaan Driehuys (Radiology, SOM), has received FDA approval for its hyperpolarized xenon gas blend, trade name XENOVIEW.

Read More

Invented at Duke 2022 brings together the university research, innovation, and entrepreneurship community

Members of the Duke research, innovation, and entrepreneurship community gathered for the annual celebration of inventions and inventors, as well as to network with each other and various internal and external partners.

Read More

Tellus Therapeutics Announces $35 Million Series A Financing

Tellus Therapeutics, a neonatal care company developing treatments for newborns in the neonatal intensive care unit (NICU), announced today the closing of a Series A financing round of $35 million led by the Perceptive Xontogeny…

Read More

Duke’s Daniel Dardani elected to the AUTM Board of Directors

As part of AUTM's Board of Directors, Duke's Daniel Dardani will help support and advance technology transfer worldwide.

Read More